30 results
424B3
PTPI
Petros Pharmaceuticals, Inc.
19 Sep 23
Prospectus supplement
4:36pm
, as amended (the “Sarbanes–Oxley Act”);
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval
POS AM
yddv9o5o467 lxs
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
oyfkkq10 1lmw7j
30 Sep 22
Preliminary proxy
4:45pm
424B3
t7dx gmysdrj
14 Jan 22
Prospectus supplement
5:18pm
424B5
b56roined93li0hrtf
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B3
gjf9lqem
20 Dec 21
Prospectus supplement
7:24am
424B5
j4d20i
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B3
yibg5dax6rj cxgnj
23 Nov 21
Prospectus supplement
4:11pm